Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending December 30, 2023 (Week 52)
Reporting Area Carbapenemase-Producing Organisms (CPO), Total §,¶
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 2 NC 6,460 NN
New England - NC 55 NN
Connecticut - NC - NN
Maine - NC - NN
Massachusetts - NC - NN
New Hampshire - NC 24 NN
Rhode Island - NC 31 NN
Vermont - NC - NN
Middle Atlantic - NC 705 NN
New Jersey - NC - NN
New York (excluding New York City) - NC - NN
New York City - NC 212 NN
Pennsylvania - NC 493 NN
East North Central - NC 1,938 NN
Illinois - NC 60 NN
Indiana - NC 313 NN
Michigan - NC 229 NN
Ohio - NC 1,303 NN
Wisconsin - NC 33 NN
West North Central - NC 175 NN
Iowa - NC 76 NN
Kansas - NC 84 NN
Minnesota - NC - NN
Missouri - NC - NN
Nebraska - NC - NN
North Dakota - NC 10 NN
South Dakota - NC 5 NN
South Atlantic - NC 743 NN
Delaware - NC 6 NN
District of Columbia - NC - NN
Florida N NC N NN
Georgia - NC 248 NN
Maryland - NC - NN
North Carolina - NC 156 NN
South Carolina - NC - NN
Virginia - NC 259 NN
West Virginia - NC 74 NN
East South Central - NC 103 NN
Alabama N NC N NN
Kentucky - NC - NN
Mississippi - NC 103 NN
Tennessee - NC - NN
West South Central - NC 18 NN
Arkansas - NC - NN
Louisiana - NC 18 NN
Oklahoma - NC - NN
Texas - NC - NN
Mountain 2 NC 712 NN
Arizona 2 NC 692 NN
Colorado - NC - NN
Idaho - NC - NN
Montana - NC - NN
Nevada - NC 2 NN
New Mexico - NC - NN
Utah - NC 18 NN
Wyoming - NC - NN
Pacific - NC 2,011 NN
Alaska - NC - NN
California - NC 1,937 NN
Hawaii - NC 5 NN
Oregon - NC 61 NN
Washington - NC 8 NN
U.S. Territories - NC 20 NN
American Samoa - NC - NN
Commonwealth of Northern Mariana Islands - NC - NN
Guam - NC - NN
Puerto Rico - NC 20 NN
U.S. Virgin Islands - NC - NN
Non-U.S. Residents - NC 1 NN
Total 2 NC 6,481 NN
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.
  • ¶ CPO (total) is the sum of CP-CRE cases reported in MMWR year 2023, CPO clinical cases, and CPO screening cases.